The National Institutes of Health's National Institute on Aging has reached an agreement with Ro, a direct-to-patient healthcare company, to create a registry for equal access to clinical trials in Alzheimer's Disease. Ro will use is telehealth platform to screen and recruit patients who may be at an elevated risk for Alzheimer's or dementia.